-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A research article published in Diabetes Care, an authoritative journal in the field of diabetes , aims to assess whether patients with type 1 diabetes (T1DM) hospitalized due to COVID-19 and patients without diabetes or type 2 diabetes (T2DM) have different risks of serious outcomes .
Diabetes COVID-19 Type 1 DiabetesThe researchers used the COVID-19 database to collect data on patients hospitalized with COVID-19 in U.
S.
Compared with non-diabetic patients, the absolute risk of ICU/MV in T1DM patients is increased by 21% (RD is 0.
21, 95% CI is 0.
19-0.
24; RR is 1.
49, 95% CI is 1.
43-1.
56), and the absolute risk of death is increased by 5% (RD is 0.
05, 95%CI is 0.
03-0.
07; RR is 1.
40, 95%CI is 1.
24-1.
57), and adjusted according to age, gender and race or ethnicity
.
Comparison of main endings
Compared with T2DM, the absolute risk of ICU/MV in T1DM patients increased by 9% (RD of 0.
09, 95% CI of 0.
07-0.
12; RR of 1.
17, 95% CI of 1.
12-1.
22), but there was no difference in mortality (RD Is 0.
00, 95%CI is -0.
02 to 0.
02; RR is 1.
00, 95%CI is 0.
89-1.
13)
.
After adjusting for diabetic ketoacidosis (DKA) that occurred before or at the time of diagnosis of COVID-19 , compared with T2DM patients, the ICU/MV risk of T1DM patients no longer increased (RD is 0.
diagnosis
It can be seen that T1DM patients hospitalized with COVID-19 are at higher risk of severe outcomes than non-diabetic patients
.
The main reason why the ICU/MV risk of T1DM patients is higher than that of T2DM patients is that they are accompanied by DKA
T1DM patients hospitalized with COVID-19 are at higher risk of severe outcomes than non-diabetic patients
.
The main reason why the ICU/MV risk of T1DM patients is higher than that of T2DM patients is that they are accompanied by DKA
.
These results further guidance COVID-19 diabetes treatment and prevention preventive original source: Intensive Care Unit Admission, Mechanical Ventilation, and Mortality Among Patients With Type 1 Diabetes Hospitalized for COVID-19 in at The US in this message